Main menu:
QHAA Group
QHAA is the Holzmann family’s holding company, an international investment group founded by Steni dr. Holzmann.
Based on the international market experience of the founder and on skills and abilities available within the Group, QHAA has developed, over time, also thanks to the fundamental contribution of large institutional partners, a network of companies aimed at offering quality goods, services and infrastructures for modern consumers and people on the move. These companies operate all over the world, in various medical-pharmaceutical sectors.
QHAA commands two distinctive areas of operations: the active management of the controlling investment in NONEP-Pharmaceutical, Pharmagenetic, Giveanhope and the dynamic management of the other investiments.
As Chairman of QHAA, dr. Holzmann leads a multidisciplinary team of professionals.
Together, they operate 24 hours a day overseeing QHAA’s growing global portfolio.
The Group monitors the market on a continuous basis so that it can take advantage of any investment opportunities which are considered suitable for creation of value, while maintaining a balanced financial structure. According to its strategic objectives, the Group rules and sustains the autonomous development of its brands.